Brain, Vol. 114, No. 2, 1045-1056, 1991
© 1991 Oxford University Press
research-article |
THE NATURAL HISTORY OF MULTIPLE SCLEROSIS: A GEOGRAPHICALLY BASED STUDY
3. MULTIVARIATE ANALYSIS OF PREDICTIVE FACTORS AND MODELS OF OUTCOME
Department of Clinical Neurological Sciences University of Western Ontario London, Ontario, Canada
Correspondence to:
Corresponding to: Dr G. C. Ebers, Department of Clinical Neurological Sciences, University Hospital, London, Ontario N6A 5a5, Canada
A multivariate hierarchical analysis was used to assess the significance of several demographic and clinical factors in multiple sclerosis patients. We used the time to reach level 6 on the disability status scale (DSS) of Kurtzke as endpoint. Several factors at presentation were significantly associated with an adverse outcome including older age at onset, male sex, cerebellar involvement or insidious onset of a motor deficit as first symptom. Factors ascertained later which were associated significantly with a worse outcome, even after controlling for those previously mentioned, included persisting deficits in brainstem, cerebellar or cerebral systems, a higher frequency of attacks in the first 2 yrs after onset of disease, a short first interattack interval and higher DSS at 2 yrs and 5 yrs from onset. An analysis similar to multiple regression was used to generate predictive models which permit the calculation of the median time to DSS 6 for patients with a given set of covariates. The goodness of fit of these models to the data and their predictive accuracy are discussed.
Received January 31, 1990. Revised June 13, 1990. Accepted June 26, 1990.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Tremlett, M. Yousefi, V. Devonshire, P. Rieckmann, Y. Zhao, and On behalf of the UBC Neurologists Impact of multiple sclerosis relapses on progression diminishes with time Neurology, November 17, 2009; 73(20): 1616 - 1623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. C. Klawiter, A. H. Cross, and R. T. Naismith The present efficacy of multiple sclerosis therapeutics: Is the new 66% just the old 33%? Neurology, September 22, 2009; 73(12): 984 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Portaccio, M. L. Stromillo, B. Goretti, V. Zipoli, G. Siracusa, M. Battaglini, A. Giorgio, M. L. Bartolozzi, L. Guidi, S. Sorbi, et al. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis Neurology, August 18, 2009; 73(7): 498 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Glad, H. Nyland, J. Aarseth, T Riise, and K. Myhr Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway Multiple Sclerosis, August 1, 2009; 15(8): 942 - 950. [Abstract] [PDF]
|
|
|
|
|
|
R. T. Naismith, N. T. Tutlam, J. Xu, J. B. Shepherd, E. C. Klawiter, S. -K. Song, and A. H. Cross Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis Neurology, July 7, 2009; 73(1): 46 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Kobelt, B Texier-Richard, and P Lindgren The long-term cost of multiple sclerosis in France and potential changes with disease-modifying interventions Multiple Sclerosis, June 1, 2009; 15(6): 741 - 751. [Abstract] [PDF]
|
|
|
|
 |
|
 M Hutchinson Predicting and preventing the future: actively managing multiple sclerosis Practical Neurology, June 1, 2009; 9(3): 133 - 143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Bichuetti, E. Oliveira, N. Souza, R. Rivero, and A. Gabbai Neuromyelitis optica in Brazil: a study on clinical and prognostic factors Multiple Sclerosis, May 1, 2009; 15(5): 613 - 619. [Abstract] [PDF]
|
|
|
|
|
|
O. Gray, H Abdeen, G. McDonnell, C. Patterson, C. Graham, and S. Hawkins An investigation of susceptibility loci in benign, aggressive and primary progressive multiple sclerosis in Northern Irish population Multiple Sclerosis, March 1, 2009; 15(3): 299 - 303. [Abstract] [PDF]
|
|
|
|
|
|
E. M. Mowry, M. Pesic, B. Grimes, S. Deen, P. Bacchetti, and E. Waubant Demyelinating events in early multiple sclerosis have inherent severity and recovery Neurology, February 17, 2009; 72(7): 602 - 608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Marrie, R. Horwitz, G. Cutter, T. Tyry, D. Campagnolo, and T. Vollmer Comorbidity delays diagnosis and increases disability at diagnosis in MS Neurology, January 13, 2009; 72(2): 117 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Hirst, G Ingram, R Swingler, D A S Compston, T Pickersgill, and N P Robertson Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis J. Neurol. Neurosurg. Psychiatry, October 1, 2008; 79(10): 1137 - 1143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Marrie, R Horwitz, G Cutter, T Tyry, D Campagnolo, and T Vollmer Comorbidity, socioeconomic status and multiple sclerosis Multiple Sclerosis, September 1, 2008; 14(8): 1091 - 1098. [Abstract] [PDF]
|
|
|
|
|
|
A Minneboo, B Jasperse, F Barkhof, B M J Uitdehaag, D L Knol, V de Groot, C H Polman, and J A Castelijns Predicting short-term disability progression in early multiple sclerosis: added value of MRI parameters J. Neurol. Neurosurg. Psychiatry, August 1, 2008; 79(8): 917 - 923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 The Optic Neuritis Study Group Multiple Sclerosis Risk After Optic Neuritis: Final Optic Neuritis Treatment Trial Follow-up Arch Neurol, June 1, 2008; 65(6): 727 - 732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Gauthier, M. Mandel, C.R.G. Guttmann, B. I. Glanz, S. J. Khoury, R. A. Betensky, and H. L. Weiner Predicting short-term disability in multiple sclerosis Neurology, June 12, 2007; 68(24): 2059 - 2065. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Edmonds, B. Vivat, R. Burman, E. Silber, and I.J. Higginson `Fighting for everything': service experiences of people severely affected by multiple sclerosis Multiple Sclerosis, June 1, 2007; 13(5): 660 - 667. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Edmonds, B. Vivat, R. Burman, E. Silber, and I. J Higginson Loss and change: experiences of people severely affected by multiple sclerosis Palliative Medicine, March 1, 2007; 21(2): 101 - 107. [Abstract] [PDF]
|
|
|
|
|
|
A.-L. Sayao, V. Devonshire, and H. Tremlett Longitudinal follow-up of "benign" multiple sclerosis at 20 years Neurology, February 13, 2007; 68(7): 496 - 500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Langer-Gould, R. A. Popat, S. M. Huang, K. Cobb, P. Fontoura, M. K. Gould, and L. M. Nelson Clinical and Demographic Predictors of Long-term Disability in Patients With Relapsing-Remitting Multiple Sclerosis: A Systematic Review Arch Neurol, December 1, 2006; 63(12): 1686 - 1691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R T Naismith, K Trinkaus, and A H Cross Phenotype and prognosis in African-Americans with multiple sclerosis: a retrospective chart review Multiple Sclerosis, November 1, 2006; 12(6): 775 - 781. [Abstract] [PDF]
|
|
|
|
|
|
P. J. Young, C. Lederer, K. Eder, M. Daumer, A. Neiss, C. Polman, L. Kappos, and on behalf of the Sylvia Lawry Centre for Multiple Relapses and subsequent worsening of disability in relapsing-remitting multiple sclerosis. Neurology, September 12, 2006; 67(5): 804 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. West, M. Wyatt, A. High, A. Bostrom, and E. Waubant Are initial demyelinating event recovery and time to second event under differential control? Neurology, September 12, 2006; 67(5): 809 - 813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C. DeLuca, K. Williams, N. Evangelou, G. C. Ebers, and M. M. Esiri The contribution of demyelination to axonal loss in multiple sclerosis Brain, June 1, 2006; 129(6): 1507 - 1516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Pittock, B. G. Weinshenker, J. H. Noseworthy, C. F. Lucchinetti, M. Keegan, D. M. Wingerchuk, J. Carter, E. Shuster, and M. Rodriguez Not every patient with multiple sclerosis should be treated at time of diagnosis. Arch Neurol, April 1, 2006; 63(4): 611 - 614. [Full Text] [PDF]
|
|
|
|
|
|
M. Kremenchutzky, G. P. A. Rice, J. Baskerville, D. M. Wingerchuk, and G. C. Ebers The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phase of the disease Brain, March 1, 2006; 129(3): 584 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Confavreux and S. Vukusic Age at disability milestones in multiple sclerosis Brain, March 1, 2006; 129(3): 595 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S L Minden, D Frankel, L Hadden, J Perloff, K P Srinath, and D C Hoaglin The Sonya Slifka Longitudinal Multiple Sclerosis Study: methods and sample characteristics Multiple Sclerosis, February 1, 2006; 12(1): 24 - 38. [Abstract] [PDF]
|
|
|
|
|
|
H. Tremlett, D. Paty, and V. Devonshire Disability progression in multiple sclerosis is slower than previously reported Neurology, January 24, 2006; 66(2): 172 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V de Groot, H Beckerman, G J Lankhorst, C H Polman, and L M Bouter The initial course of daily functioning in multiple sclerosis: a three-year follow-up study Multiple Sclerosis, December 1, 2005; 11(6): 713 - 718. [Abstract] [PDF]
|
|
|
|
|
|
S J Pittock, R L McClelland, S J Achenbach, F Konig, A Bitsch, W Bruck, H Lassmann, J E Parisi, B W Scheithauer, M Rodriguez, et al. Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease J. Neurol. Neurosurg. Psychiatry, December 1, 2005; 76(12): 1693 - 1697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Barkhof, U. Held, J. H. Simon, M. Daumer, F. Fazekas, M. Filippi, J. A. Frank, L. Kappos, D. Li, S. Menzler, et al. Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trials Neurology, November 8, 2005; 65(9): 1447 - 1454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A.C. Cree, O. Khan, D. Bourdette, D. S. Goodin, J. A. Cohen, R. A. Marrie, D. Glidden, B. Weinstock-Guttman, D. Reich, N. Patterson, et al. Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis Neurology, December 14, 2004; 63(11): 2039 - 2045. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A.J. Visschedijk, B. M.J. Uitdehaag, M. Klein, E. van der Ploeg, E. H. Collette, L. Vleugels, L. E.M.A. Pfennings, E. L.J. Hoogervorst, H. M. van der Ploeg, and C. H. Polman Value of health-related quality of life to predict disability course in multiple sclerosis Neurology, December 14, 2004; 63(11): 2046 - 2050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. H. Stuart, S. Cohan, J. R. Richert, and A. Achiron Selecting a disease-modifying agent as platform therapy in the long-term management of multiple sclerosis Neurology, December 14, 2004; 63(11_suppl_5): S19 - S27. [Abstract] [Full Text]
|
|
|
|
|
|
R. J Buchanan, R. A Martin, M. Zuniga, S. Wang, and M. Kim Nursing home residents with multiple sclerosis: comparisons of African American residents to white residents at admission Multiple Sclerosis, December 1, 2004; 10(6): 660 - 667. [Abstract] [PDF]
|
|
|
|
|
|
Optic Neuritis Study Group Neurologic Impairment 10 Years After Optic Neuritis Arch Neurol, September 1, 2004; 61(9): 1386 - 1389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Surakka, A. Romberg, J. Ruutiainen, S. Aunola, A. Virtanen, S.-L. Karppi, and K. Maentaka Effects of aerobic and strength exercise on motor fatigue in men and women with multiple sclerosis: a randomized controlled trial Clinical Rehabilitation, July 1, 2004; 18(7): 737 - 746. [Abstract] [PDF]
|
|
|
|
|
|
P. Fox, P. G. Bain, S. Glickman, C. Carroll, and J. Zajicek The effect of cannabis on tremor in patients with multiple sclerosis Neurology, April 13, 2004; 62(7): 1105 - 1109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Pittock, W. T. Mayr, R. L. McClelland, N. W. Jorgensen, S. D. Weigand, J. H. Noseworthy, B. G. Weinshenker, and M. Rodriguez Change in MS-related disability in a population-based cohort: A 10-year follow-up study Neurology, January 13, 2004; 62(1): 51 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rovaris, F. Agosta, M. P. Sormani, M. Inglese, V. Martinelli, G. Comi, and M. Filippi Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study Brain, October 1, 2003; 126(10): 2323 - 2332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. Boneschi, M. Rovaris, K. P Johnson, A. Miller, J. S Wolinsky, D. Ladkani, G. Shifroni, G. Comi, and M. Filippi Effects of glatiramer acetate on relapse rate and accumulated disability in multiple sclerosis: meta-analysis of three double-blind, randomized, placebo-controlled clinical trials Multiple Sclerosis, August 1, 2003; 9(4): 349 - 355. [Abstract] [PDF]
|
|
|
|
|
|
M. Eriksson, O. Andersen, and B. Runmarker Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis Multiple Sclerosis, June 1, 2003; 9(3): 260 - 274. [Abstract] [PDF]
|
|
|
|
|
|
T. F Scott, C. J Schramke, and G. Cutter Sample size estimates for determining treatment effects in high-risk patients with early relapsing-remitting multiple sclerosis Multiple Sclerosis, June 1, 2003; 9(3): 289 - 292. [Abstract] [PDF]
|
|
|
|
|
|
C. Confavreux, S. Vukusic, and P. Adeleine Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process Brain, April 1, 2003; 126(4): 770 - 782. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L M Sudlow and C. E Counsell Problems with UK government's risk sharing scheme for assessing drugs for multiple sclerosis BMJ, February 15, 2003; 326(7385): 388 - 392. [Full Text] [PDF]
|
|
|
|
|
|
I. L. Simone, D. Carrara, C. Tortorella, M. Liguori, V. Lepore, F. Pellegrini, A. Bellacosa, A. Ceccarelli, I. Pavone, and P. Livrea Course and prognosis in early-onset MS: Comparison with adult-onset forms Neurology, December 24, 2002; 59(12): 1922 - 1928. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Burks, B. G. Arnason, P. K. Coyle, C. C. Ford, A. Noronha, and K. W. Rammohan Issues and Practices in Multiple Sclerosis Neurorehabil Neural Repair, December 1, 2002; 16(4): 307 - 320. [Abstract] [PDF]
|
|
|
|
|
|
M-L Sumelahti, P J Tienari, J Wikstrom, T M Salminen, and M Hakama Survival of multiple sclerosis in Finland between 1964 and 1993 Multiple Sclerosis, August 1, 2002; 8(4): 350 - 355. [Abstract] [PDF]
|
|
|
|
 |
|
 A R Lorenzi and H L Ford Multiple sclerosis and pregnancy Postgrad. Med. J., August 1, 2002; 78(922): 460 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T Masterman, Z Zhang, D Hellgren, H Salter, M Anvret, L Lilius, L Lannfelt, and J Hillert APOE genotypes and disease severity in multiple sclerosis Multiple Sclerosis, April 1, 2002; 8(2): 98 - 103. [Abstract] [PDF]
|
|
|
|
|
|
G C Ebers NATURAL HISTORY OF MULTIPLE SCLEROSIS J. Neurol. Neurosurg. Psychiatry, December 1, 2001; 71(suppl_2): ii16 - ii19. [Full Text] [PDF]
|
|
|
|
|
|
G. Ramsaransing, N. Maurits, C. Zwanikken, and J. De Keyser Early prediction of a benign course of multiple sclerosis on clinical grounds: a systematic review Multiple Sclerosis, October 1, 2001; 7(5): 345 - 347. [Abstract] [PDF]
|
|
|
|
|
|
S. H. Alusi, J. Worthington, S. Glickman, and P. G. Bain A study of tremor in multiple sclerosis Brain, April 1, 2001; 124(4): 720 - 730. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chapman, S. Vinokurov, A. Achiron, D. M. Karussis, K. Mitosek-Szewczyk, M. Birnbaum, D. M. Michaelson, and A. D. Korczyn APOE genotype is a major predictor of long-term progression of disability in MS Neurology, February 13, 2001; 56(3): 312 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K M Myhr, T Riise, C Vedeler, M W Nortvedt, M Gronning, R Midgard, and H I Nyland Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension Multiple Sclerosis, February 1, 2001; 7(1): 59 - 65. [Abstract] [PDF]
|
|
|
|
|
|
M. A. A. van Walderveen, G. J. Lycklama a Nijeholt, H. J. Ader, P. J. H. Jongen, C. H. Polman, J. A. Castelijns, and F. Barkhof Hypointense Lesions on T1-Weighted Spin-Echo Magnetic Resonance Imaging: Relation to Clinical Characteristics in Subgroups of Patients With Multiple Sclerosis Arch Neurol, January 1, 2001; 58(1): 76 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Comi, M. Leone, S. Bonissoni, S. DeFranco, F. Bottarel, C. Mezzatesta, A. Chiocchetti, F. Perla, F. Monaco, and U. Dianzani Defective T cell Fas function in patients with multiple sclerosis Neurology, October 10, 2000; 55(7): 921 - 927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. F. Scott, C. J. Schramke, J. Novero, and C. Chieffe Short-term prognosis in early relapsing-remitting multiple sclerosis Neurology, September 12, 2000; 55(5): 689 - 693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K P Johnson, B R Brooks, C C Ford, A Goodman, J Guarnaccia, R P Lisak, L W Myers, H S Panitch, A Pruitt, J W Rose, et al. Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years Multiple Sclerosis, August 1, 2000; 6(4): 255 - 266. [Abstract] [PDF]
|
|
|
|
|
|
D. Parkin, A. Jacoby, P. McNamee, P. Miller, S. Thomas, and D. Bates Treatment of multiple sclerosis with interferon beta : an appraisal of cost-effectiveness and quality of life J. Neurol. Neurosurg. Psychiatry, February 1, 2000; 68(2): 144 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L D Jacobs, K E Wende, C M Brownscheidle, B Apatoff, P K Coyle, A Goodman, M H Gottesman, C V Granger, S J Greenberg, J Herbert, et al. A profile of multiple sclerosis: The New York State Multiple Sclerosis Consortium Multiple Sclerosis, October 1, 1999; 5(5): 369 - 376. [Abstract] [PDF]
|
|
|
|
|
|
M. Kremenchutzky, D. Cottrell, G. Rice, W. Hader, J. Baskerville, W. Koopman, and G. C. Ebers The natural history of multiple sclerosis: a geographically based study: 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation Brain, October 1, 1999; 122(10): 1941 - 1950. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S A Hawkins and G V McDonnell Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors J. Neurol. Neurosurg. Psychiatry, August 1, 1999; 67(2): 148 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Sorensen, J. L. Frederiksen, H. Bronnum-Hansen, and H. C. Petersen Optic neuritis as onset manifestation of multiple sclerosis: A nationwide, long-term survey Neurology, August 1, 1999; 53(3): 473 - 473. [Abstract] [Full Text]
|
|
|
|
|
|
Z M Levic, I Dujmovic, T Pekmezovic, M Jarebinski, J Marinkovic, N Stojsavljevic, and J Drulovic Prognostic factors for survival in multiple sclerosis Multiple Sclerosis, June 1, 1999; 5(3): 171 - 178. [Abstract] [PDF]
|
|
|
|
|
|
K.-M. Myhr, G. Raknes, H. Nyland, and C. Vedeler Immunoglobulin G Fc-receptor (Fc{gamma}R) IIA and IIIB polymorphisms related to disability in MS Neurology, June 1, 1999; 52(9): 1771 - 1771. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S Goodin and Northern California MS Study Group Survey of multiple sclerosis in Northern California Multiple Sclerosis, April 1, 1999; 5(2): 78 - 88. [Abstract] [PDF]
|
|
|
|
|
|
D. A. Cottrell, M. Kremenchutzky, G. P. A. Rice, W. J. Koopman, W. Hader, J. Baskerville, and G. C. Ebers The natural history of multiple sclerosis:a geographically based study: 5. The clinical features and natural history of primary progressive multiple sclerosis Brain, April 1, 1999; 122(4): 625 - 639. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Cottrell, M. Kremenchutzky, G. P. A. Rice, W. Hader, J. Baskerville, and G. C. Ebers The natural history of multiple sclerosis: a geographically based study: 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis Brain, April 1, 1999; 122(4): 641 - 647. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S H ALUSI, S GLICKMAN, T Z AZIZ, and P G BAIN Tremor in multiple sclerosis J. Neurol. Neurosurg. Psychiatry, February 1, 1999; 66(2): 131 - 134. [Full Text]
|
|
|
|
|
|
M. Sailer, J. I. O'Riordan, A. J. Thompson, D. P. Kingsley, D. G. MacManus, W. I. McDonald, and D. H. Miller Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination Neurology, February 1, 1999; 52(3): 599 - 599. [Abstract] [Full Text]
|
|
|
|
|
|
C. C. Whitacre Summary and Future Directions Multiple Sclerosis, December 1, 1998; 4(6): 516 - 518. [PDF]
|
|
|
|
 |
|
 R. A. Rudick A 29-Year-Old Man With Multiple Sclerosis JAMA, October 28, 1998; 280(16): 1432 - 1439. [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Rudick, J. A. Cohen, B. Weinstock-Guttman, R. P. Kinkel, and R. M. Ransohoff Management of Multiple Sclerosis N. Engl. J. Med., November 27, 1997; 337(22): 1604 - 1611. [Full Text] [PDF]
|
|
|
|
|
|
A. Ghezzi, V. Deplano, J. Faroni, M. Grasso, M. Liguori, G. Marrosu, C. Pozzilli, I. Simone, and M. Zaffaroni Multiple sclerosis in childhood: clinical features of 149 cases Multiple Sclerosis, February 1, 1997; 3(1): 43 - 46. [Abstract] [PDF]
|
|
|
|
|
|
J. H Noseworthy Interferon {beta}-1b: latest published results, 1995 Multiple Sclerosis, June 1, 1996; 1(6): 313 - 316. [Abstract] [PDF]
|
|
|
|
|
|
G Comi, V Martinelli, and M Filippi Interferon beta treatment in multiple sclerosis: the European clinical trials Multiple Sclerosis, June 1, 1996; 1(6): 317 - 320. [PDF]
|
|
|
|
|
|
B. G. Weinshenker, M. Issa, and J. Baskerville Long-term and Short-term Outcome of Multiple Sclerosis: A 3-Year Follow-up Study Arch Neurol, April 1, 1996; 53(4): 353 - 358. [Abstract] [PDF]
|
|
|
|
|
|
R. Rudick, S. Medendorp, M Namey, S Boyle, and J Fischer Multiple sclerosis progression in a natural history study: Predictive value of cerebrospinal fluid free kappa light chains Multiple Sclerosis, November 1, 1995; 1(3): 150 - 155. [Abstract] [PDF]
|
|